APA (7th ed.) Citation

Aparina, T. V., Britov, A. N., Dilakyan, E. A., Metelskaya, V. A., & Gomazkov, O. A. (2001). SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Aparina, T. V., A. N. Britov, E. A. Dilakyan, V. A. Metelskaya, and O. A. Gomazkov. SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED. «FIRMA «SILICEA» LLC, 2001.

MLA (9th ed.) Citation

Aparina, T. V., et al. SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED. «FIRMA «SILICEA» LLC, 2001.